Early-onset atopic dermatitis (AD) related repression of the immune regulatory NLRP2 is driven by promoter hypermethylation starting already at time of birth providing an early opportunity to modulate innate immunity to potentially mitigate AD development.
http://ift.tt/2kfnRvH
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου